Tumor-associated inflammation is associated with prognosis because it is documented by the Glasgow Prognostic Score that combines serum CRP and albumin levels and stratifies prognosis in various cancers including PDAC.30,31 The combination of biologic and inflammatory tumor markers in PDAC was recently used to create a pretreatment score to stratify the survival of PDAC patients more precisely.32 This evidence concerns the gene ALB and cancer.